Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Jan 26, 2013
Making Another Call on Precision Castparts; Raising Our Fair Value Estimate Materially
Precision Castparts announced solid fiscal third-quarter results and offered its estimate for synergies related to the Titanium Metals deal. We expect management to deliver in a big way. Jan 25, 2013
Tales from the Rails
Let’s take a look at recent earnings from the large US rail operators. Jan 24, 2013
Apple's Fiscal First-Quarter Weekly Revenue Up 27%; Bottom-Line Earnings Beat; Street Is Off Its Rocker
The market is over-reacting to one of the best quarters ever put up by a technology company. Apple's $137 billion cash hoard means it could buy almost any company in the world--one in its supply chain to boost gross margins or even some of the largest companies with fast-growing operations (and high P/E's) that Apple bears may like. There is simply no justification for the magnitude of the sell-off on this single-digit P/E company, but we expect negative sentiment to continue to push down shares over the near term. Jan 24, 2013
United Technologies Looks to a Strong 2013 After a Transformative 2012
United Technologies' increased aerospace exposure should position it well for 2013. Jan 23, 2013
Best Ideas Portfolio Holding Intuitive Surgical Is Surging Today
The bear case fails to materialize at Intuitive Surgical. The company's fourth-quarter performance has sent the shares soaring. Jan 23, 2013
Best Ideas Newsletter Portfolio Holding Google Rebounds with a Strong Fourth Quarter
Google follows up a tough third quarter with a great fourth quarter. Jan 23, 2013
Agriculture Stands Out During DuPont’s Fourth Quarter
Agriculture strength helped offset weak chemical results at DuPont. Our $57 per share fair value estimate remains unchanged. Jan 18, 2013
Intel Punished for Investing in the Future
Shares of Intel remain cheap and pay out a hefty dividend. Jan 18, 2013
Is Genworth a Gem Worth Looking At?
Let's take a look at Genworth Financial. Jan 18, 2013
The Future of Omega Healthcare Looks Promising
Let’s dig into Omega Healthcare.
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657585960616263646566676869707172737475 767778798081828384858687888990919293949596979899100 101102103104105106107108109110111112113114115116117118119120 121122123124125126127128129130131132133134135136137138139140 141142143144145146147148149150151152153154155156157158159160 161162163164165166167168169170171172173174175176177178179180 181182183184185186187188189190191192193194195196197198199200 201202203204205206207208209210211212213214215216217218219220 221222223224225226227228229230231232233234235236237238239240 241242243244245246247248249250251252253254255256257258259260 261262263264265266267268269270271272273274275276277278279280 281282283284285286287288289290291292293294295296297298299300 301302303304305306307308309310311312313314315316317318319320 321322323324325326327328329330331332333334335336337338339340 341342343344345346347348349350351352353next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|